These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31593759)

  • 1. In Vitro Benchmarking Study of Ventricular Assist Devices in Current Clinical Use.
    Radley G; Pieper IL; Robinson CR; Ali S; Beshr M; Bodger O; Thornton CA
    J Card Fail; 2020 Jan; 26(1):70-79. PubMed ID: 31593759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CentriMag centrifugal blood pump as a benchmark for in vitro testing of hemocompatibility in implantable ventricular assist devices.
    Chan CH; Pieper IL; Hambly R; Radley G; Jones A; Friedmann Y; Hawkins KM; Westaby S; Foster G; Thornton CA
    Artif Organs; 2015 Feb; 39(2):93-101. PubMed ID: 25066768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shear Stress-Induced Total Blood Trauma in Multiple Species.
    Chan CHH; Pieper IL; Robinson CR; Friedmann Y; Kanamarlapudi V; Thornton CA
    Artif Organs; 2017 Oct; 41(10):934-947. PubMed ID: 28744884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparison of the hemocompatibility of two centrifugal left ventricular assist devices.
    Zayat R; Moza A; Grottke O; Grzanna T; Fechter T; Motomura T; Schmidt-Mewes C; Breuer T; Autschbach R; Rossaint R; Goetzenich A; Bleilevens C
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):591-599.e4. PubMed ID: 30414772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Toroidal-Flow Left Ventricular Assist Device Minimizes Blood Trauma: Implications of Improved Ventricular Assist Device Hemocompatibility.
    Bartoli CR; Hennessy-Strahs S; Gohean J; Villeda M; Larson E; Longoria R; Kurusz M; Acker MA; Smalling R
    Ann Thorac Surg; 2019 Jun; 107(6):1761-1767. PubMed ID: 30586577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Numerical Analysis of Blood Damage Potential of the HeartMate II and HeartWare HVAD Rotary Blood Pumps.
    Thamsen B; Blümel B; Schaller J; Paschereit CO; Affeld K; Goubergrits L; Kertzscher U
    Artif Organs; 2015 Aug; 39(8):651-9. PubMed ID: 26234447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovine Leukocyte Microparticles Generated by the CentriMag Ventricular Assist Device In Vitro.
    Pieper IL; Radley G; Christen A; Ali S; Bodger O; Thornton CA
    Artif Organs; 2018 Jun; 42(6):E78-E89. PubMed ID: 29512167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
    Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
    JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart.
    Reich HJ; Morgan J; Arabia F; Czer L; Moriguchi J; Ramzy D; Esmailian F; Lam L; Dunhill J; Volod O
    J Thromb Haemost; 2017 Aug; 15(8):1620-1624. PubMed ID: 28586149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
    Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
    J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
    Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
    JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System.
    Bartoli CR; Kang J; Zhang D; Howard J; Acker M; Atluri P; Motomura T
    Ann Thorac Surg; 2017 Apr; 103(4):1239-1244. PubMed ID: 27717422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Hemocompatibility Evaluation of Ventricular Assist Devices in Pediatric Flow Conditions: A Benchmark Study.
    Chan CHH; Diab S; Moody K; Frazier OH; Sampaio LC; Fraser CD; Teruya J; Adachi I
    Artif Organs; 2018 Nov; 42(11):1028-1034. PubMed ID: 30101559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
    Kang J; Zhang DM; Restle DJ; Kallel F; Acker MA; Atluri P; Bartoli CR
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1747-1754.e1. PubMed ID: 26971377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding.
    Chen Z; Zhang J; Kareem K; Tran D; Conway RG; Arias K; Griffith BP; Wu ZJ
    Artif Organs; 2019 Aug; 43(8):745-755. PubMed ID: 30805954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.
    Bartoli CR; Kang J; Motomura T
    J Card Surg; 2020 Jul; 35(7):1477-1483. PubMed ID: 32652785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
    Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices.
    Hu J; Mondal NK; Sorensen EN; Cai L; Fang HB; Griffith BP; Wu ZJ
    J Heart Lung Transplant; 2014 Jan; 33(1):71-9. PubMed ID: 24055626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis.
    Bartoli CR; Zhang D; Kang J; Hennessy-Strahs S; Restle D; Howard J; Redline G; Bermudez C; Atluri P; Acker MA
    Ann Thorac Surg; 2018 Mar; 105(3):807-814. PubMed ID: 28942075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.